Viva Biotech Holdings
HKEX:1873.HK
0.61 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 1,036.322 | 678.569 | 800.947 | 2,308.452 | 904.091 | 155.554 | 29.766 | 13.425 |
| Short Term Investments
| 0 | 0 | 0 | 49.5 | 29.629 | 0 | 3.5 | 0 |
| Cash and Short Term Investments
| 1,036.322 | 678.569 | 800.947 | 2,357.952 | 933.72 | 155.554 | 33.266 | 13.425 |
| Net Receivables
| 407.405 | 445.969 | 429.703 | 320.51 | 57.505 | 51.461 | 28.637 | 19.737 |
| Inventory
| 259.707 | 326.031 | 231.721 | 164.745 | 8.53 | 4.9 | 3.323 | 1.013 |
| Other Current Assets
| 327.484 | 488.238 | 521.414 | 557.837 | 124.3 | 29.255 | 46.858 | 50.726 |
| Total Current Assets
| 2,030.918 | 1,938.807 | 1,983.785 | 3,351.544 | 1,094.426 | 241.17 | 83.447 | 65.164 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 1,660.938 | 1,937.38 | 1,723.901 | 737.01 | 156.986 | 66.899 | 34.4 | 21.343 |
| Goodwill
| 2,156.419 | 2,156.419 | 2,156.419 | 1,847.723 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 420.669 | 476.061 | 531.444 | 469.462 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 2,577.088 | 2,632.48 | 2,687.863 | 2,317.185 | 780.279 | 0 | 0 | -12.122 |
| Long Term Investments
| 1,038.184 | 1,046.616 | 1,246.73 | 924.532 | 627.082 | 210.017 | 74.069 | 12.122 |
| Tax Assets
| 21.186 | 18.178 | 7.63 | 9.943 | 3.789 | 0 | 1.461 | 1.4 |
| Other Non-Current Assets
| 121.598 | -18.178 | -7.63 | -9.943 | -784.068 | 11.253 | 9.025 | 13.914 |
| Total Non-Current Assets
| 5,418.994 | 5,616.476 | 5,658.494 | 3,978.727 | 784.068 | 288.169 | 118.955 | 36.657 |
| Total Assets
| 7,449.912 | 7,920.855 | 8,044.758 | 8,154.08 | 1,898.785 | 529.339 | 202.402 | 101.821 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 245.756 | 326.13 | 281.053 | 295.704 | 7.552 | 4.685 | 3.767 | 1.575 |
| Short Term Debt
| 952.441 | 1,916.18 | 238.744 | 166.965 | 24.983 | 0.497 | 12.583 | 0.673 |
| Tax Payables
| 39.632 | 55.995 | 58.589 | 60.071 | 12.09 | 0 | 7.964 | 3.981 |
| Deferred Revenue
| -2.929 | -1,916.18 | -238.744 | -166.965 | -24.983 | 0 | 0 | 0 |
| Other Current Liabilities
| 338.91 | 2,346.427 | 645.55 | 439.968 | 65.411 | 37.28 | 20.641 | 14.072 |
| Total Current Liabilities
| 1,534.178 | 2,672.557 | 926.603 | 735.672 | 72.963 | 42.462 | 36.991 | 16.32 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 950.776 | 880.959 | 2,388.179 | 2,798.634 | 1.34 | 222.465 | 2.362 | 2.833 |
| Deferred Revenue Non-Current
| 55.023 | 73.123 | 75.269 | 22.71 | 15.844 | 0 | 10.287 | 6.166 |
| Deferred Tax Liabilities Non-Current
| 69.192 | 92.201 | 117.731 | 119.184 | 8.16 | 0 | 2.362 | 2.833 |
| Other Non-Current Liabilities
| 1,152.831 | -165.324 | -193 | -141.894 | -24.004 | 12.97 | -2.362 | -2.833 |
| Total Non-Current Liabilities
| 2,227.822 | 880.959 | 2,388.179 | 2,798.634 | 1.34 | 235.435 | 12.649 | 8.999 |
| Total Liabilities
| 3,762 | 4,316.141 | 4,131.402 | 4,397.249 | 121.391 | 277.897 | 49.64 | 25.319 |
| Equity: | ||||||||
| Preferred Stock
| 418.521 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.367 | 0.326 | 0.326 | 0.323 | 0.261 | 0.164 | 0.12 | 0.12 |
| Retained Earnings
| -418.521 | -178.395 | 350.08 | 62.534 | 449.414 | 183.542 | 83.72 | 13.699 |
| Accumulated Other Comprehensive Income/Loss
| 3,822.196 | 280.484 | 60.651 | 95.896 | 29.046 | 20.485 | -24.12 | -18.817 |
| Other Total Stockholders Equity
| -134.651 | 3,502.299 | 3,502.299 | 3,598.078 | 1,298.673 | 47.251 | 93.042 | 81.5 |
| Total Shareholders Equity
| 3,687.912 | 3,604.714 | 3,913.356 | 3,756.831 | 1,777.394 | 251.442 | 152.762 | 76.502 |
| Total Equity
| 3,687.912 | 3,604.714 | 3,913.356 | 3,756.831 | 1,777.394 | 251.442 | 152.762 | 76.502 |
| Total Liabilities & Shareholders Equity
| 7,449.912 | 7,920.855 | 8,044.758 | 8,154.08 | 1,898.785 | 529.339 | 202.402 | 101.821 |